Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives Consensus Recommendation of "Hold" from Analysts

robot
Abstract generation in progress

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has received a consensus “Hold” recommendation from analysts, with an average 12-month price target of approximately $105.95. The company recently surpassed Q4 earnings estimates with EPS of $2.42 and revenue of $2.24 billion, and has provided FY2026 guidance with an EPS range of $8.30-$8.45. Institutional investors own a significant portion of the stock, with various hedge funds increasing their positions.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin